19 results
6-K
EX-99.1
CALT
Calliditas Therapeutics AB
28 Apr 23
Current report (foreign)
4:05pm
that environmental considerations are embedded in our supplier selection process. We remain accountable for understanding the environmental impact of our supply
6-K
EX-10.1
x51cep
19 Jul 21
Calliditas secures $75 million term loan facility
7:20am
20-F
07pn3 1no3k5
27 Apr 21
Annual report (foreign)
5:16pm
F-1
qn2eb
26 Jan 21
Registration statement (foreign)
4:33pm
F-1
EX-10.14
1gttcta4h
26 Jan 21
Registration statement (foreign)
4:33pm
DRS
gtfuz8fesai8m3po efm
29 Dec 20
Draft registration statement
12:00am
424B4
p6alcn
8 Jun 20
Prospectus supplement with pricing info
9:18am
F-1/A
acmcb2x
1 Jun 20
Registration statement (foreign) (amended)
7:01am
F-1
d3kz9npbq2c8mz7nu4
14 May 20
Registration statement (foreign)
8:56am
F-1
EX-10.12
0sr 4rky4r6hba
14 May 20
Registration statement (foreign)
8:56am
DRS/A
EX-10.11
tw5v3 48idtc69
2 Mar 20
Draft registration statement (amended)
12:00am
DRS/A
j54484o84w
2 Mar 20
Draft registration statement (amended)
12:00am
DRS
xfw340
13 Dec 19
Draft registration statement
12:00am
- Prev
- 1
- Next